Postpartum Hemorrhage

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The High-Flow Uteroplacental Circuit: At term gestation, the maternal-fetal circulation is a low-resistance, high-flow system, with blood flowing to the gravid uterus at a rate of 500 to 700 mL/min, representing approximately 15% of maternal cardiac output.
• Myometrial Mechanical Hemostasis: Following delivery of the fetus and placenta, the uterine spiral arteries—which directly supply the placental bed—are sheared open. Hemostasis relies almost entirely on the mechanical contraction of the surrounding interlacing myometrial muscle fibers (referred to as the "physiological ligatures") which physically constrict the uterine blood vessels.
• Decoupling of the Hemostatic Mechanism (Atony): Uterine atony occurs when the myometrium fails to contract, resulting in uninhibited, rapid maternal exsanguination from the placental attachment site. This mechanical failure is often triggered by myometrial fatigue (due to prolonged labor, prolonged oxytocin exposure, or chorioamnionitis) or uterine overdistension (due to multifetal gestation, polyhydramnios, or macrosomia).
• Systemic Coagulation Failures: Localized clotting factor depletion can occur due to consumption (e.g., in the setting of severe preeclampsia, placental abruption, or amniotic fluid embolism). Normal pregnancy is a hypercoagulable state with elevated fibrinogen levels (400 to 450 mg/dL); a drop below 300 mg/dL indicates a highly pathological consumptive coagulopathy that impairs clot stabilization and exacerbates hemorrhage.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

Immediate, parallel resuscitation and hemorrhage control are mandatory. Maternal resuscitation is the primary priority.

• Step 1: Empiric Uterine Compressions: Immediately initiate continuous, aggressive bimanual uterine massage to stimulate myometrial contractions. Perform this by placing a gloved fist into the anterior vaginal fornix and compressing the uterine fundus anteriorly against the abdominal wall.
• Step 2: Dual Large-Bore Access: Establish at least two large-bore (14G or 16G) peripheral IV lines, preferentially above the diaphragm. Avoid lower extremity or femoral central access due to mechanical venous obstruction by the persistently enlarged postpartum uterus.
• Step 3: Aggressive Balanced Resuscitation:
• Initiate rapid volume expansion with warm isotonic crystalloids (0.9% NaCl or Lactated Ringer’s).
• If hemodynamic instability is not corrected after an initial crystalloid bolus or if maternal hemoglobin is <10 g/dL, initiate immediate blood transfusions.
• If unstable after 2 to 4 units of PRBCs, activate the Massive Transfusion Protocol (MTP) using a balanced 1:1:1 ratio (PRBCs, fresh frozen plasma [FFP], and platelets).
• Step 4: Execute Sequential Uterotonic Pharmacotherapy:
• First-Line: Oxytocin — Infuse 20 to 40 International Units (IU) in 500 to 1,000 mL of 0.9% NaCl or RL as a continuous IV infusion over 4 hours (recommend starting with 20 IU). If IV access is unavailable, immediately administer 10 IU intramuscularly (IM).
• Second-Line Options (Administer in parallel or sequentially based on patient factors):
• Methylergonovine (Methergine): Administer 0.2 mg IM every 2 to 4 hours as needed (maximum 5 doses). Contraindication: Strictly contraindicated in patients with coronary artery disease (CAD), preeclampsia, or gestational hypertension.
• Carboprost (Hemabate): Administer 250 μg IM every 15 to 90 minutes as needed (maximum 8 doses/2,000 μg). Contraindication: Strictly contraindicated in patients with active asthma.
• Misoprostol (Cytotec): Administer 600 to 1,000 μg orally, or rectally if the patient cannot tolerate oral medications, or 800 μg sublingually as a single dose.
• Step 5: Antifibrinolytic Administration: Administer Tranexamic Acid (TXA) 1,000 mg (1 g) IV over 10 minutes; may repeat once within 24 hours if active hemorrhage persists.
• Step 6: Bedside Tamponade: If uterine atony is refractory to massage and uterotonics, immediately place an intrauterine balloon tamponade device (such as a Bakri or Rüsch balloon, or a sterile Foley catheter/condom adaptation) or apply lower-level intrauterine vacuum (such as the Jada System) to compress the endometrial vasculature.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

The "4 Ts" Differential Mnemonic:

1. Tone (Uterine Atony): Responsible for 70% to 80% of all cases. Characterized by a soft, boggy, poorly contracted uterus on palpation.
2. Trauma (Genital Tract Lacerations or Hematomas): Accounts for up to 20% of cases. Characterized by persistent, brisk vaginal bleeding of bright red blood despite a firm, well-contracted uterus. Must inspect for vaginal, cervical, perineal, or urethral tears, or expanding pelvic/vulvar hematomas.
3. Tissue (Retained Products of Conception): Accounts for approximately 10% of cases. Suspected when the placenta is noted to be non-intact on inspection, or when there is a history of delayed placental delivery (>30 minutes). Also represents the most common cause of secondary postpartum hemorrhage (>24 hours to 12 weeks postpartum).
4. Thrombin (Coagulopathy): An uncommon primary cause but a frequent secondary complication of severe hemorrhage, preeclampsia, sepsis, or amniotic fluid embolism. Suspect in patients with persistent bleeding from IV venipuncture sites, surgical wounds, or mucosal surfaces.

Prioritized Emergency Workup Strategy:

• Quantitative Blood Loss (QBL): Do not rely on visual estimations, which are notoriously inaccurate. Track blood loss volume and monitor for clinical signs of hypovolemia.
• Urgent Type and Crossmatch: Crossmatch for 4 to 6 units of PRBCs immediately.
• Complete Blood Count (CBC) and Coagulation Panel: Obtain platelets, PT/INR, aPTT, and quantitative fibrinogen levels.
• Viscoelastic Testing (TEG/ROTEM): Where available, obtain to guide real-time, targeted clotting factor and cryoprecipitate replacement during massive resuscitation.
• Urinalysis & Urine Culture: Essential if presenting with secondary postpartum bleeding and fever to rule out concurrent urinary tract infection or pyelonephritis.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• Standard 12-Lead ECG Checklist:
• Exclude acute myocardial infarction or right ventricular strain from massive pulmonary embolism, which are key mimics of postpartum collapse.
• Identify normal physiologic postpartum ECG changes: a leftward shift of the QRS axis (due to diaphragm elevation during pregnancy), transient T-wave flattening or inversions in lead III, and minor ST-segment changes that can mimic ischemia.
• Point-of-Care Ultrasound (POCUS) / Echocardiography View:
• Intrauterine Evaluation: Place a low-frequency transducer transabdominally over the suprapubic region to scan the uterine cavity. Look for echogenic, irregular intracavitary masses or debris representing retained products of conception or placenta.
• Fluid-Filled Cavity: Identify an abnormally enlarged, fluid-filled uterine cavity containing blood clots, which suggests occult hemorrhage or ineffective myometrial contraction.
• The Focused Assessment with Sonography for Trauma (FAST) Sweep: Scan Morison's pouch and the splenorenal recess to screen for free intraperitoneal fluid, which is highly concerning for uterine rupture or intra-abdominal hemorrhage.
• Cardiac Evaluation: Obtain a parasternal long-axis and apical 4-chamber view to assess for right ventricular strain (pulmonary embolism) or global left ventricular hypokinesis (peripartum cardiomyopathy) in any patient with cardiovascular collapse.
• Computed Tomography (CT) of the Abdomen & Pelvis:
• Indicated only in hemodynamically stable patients to identify suspected deep intra-pelvic or retroperitoneal hematomas, uterine rupture, or to evaluate for septic pelvic thrombophlebitis in stable febrile patients.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

1. Clinical Definition of Postpartum Hemorrhage (ACOG 2017):

The diagnosis of postpartum hemorrhage is established when either of the following criteria is met within 24 hours of birth, regardless of the delivery route:

1. Cumulative blood loss \(\ge\) 1,000 mL.
2. Vaginal bleeding associated with any signs or symptoms of maternal hypovolemia (such as tachycardia, hypotension, dizziness, or poor peripheral perfusion).

2. Physiological Compensation and Vital Sign Thresholds:

Because of the physiologic 30% to 50% increase in blood volume during pregnancy, maternal vital signs are poor early indicators of blood loss.

• The 25% Blood Loss Threshold: A postpartum patient can maintain completely normal blood pressures and show no symptoms of hypovolemia until they have lost approximately 25% of their total blood volume (approximately \(\ge\) 1,500 mL).
• Late Red Flags: The sudden onset of maternal tachycardia and hypotension is an ominous, late sign indicating that considerable, life-threatening blood loss has already occurred and compensatory mechanisms are failing.

3. Emergency Department Disposition Guidelines:

• ICU or Labor & Delivery Admission Mandate: Any patient requiring active resuscitation, MTP activation, or balloon/vacuum uterine tamponade must be admitted to a high-dependency unit, ICU, or L&D suite capable of advanced surgical and hemodynamic monitoring.
• Outpatient Discharge Criteria (Secondary PPH Only): A patient presenting with mild secondary bleeding (>24 hours postpartum) may be considered for discharge only if:

    1.  The bleeding has completely slowed to a normal lochial flow.
    2.  Maternal vital signs are entirely normal.
    3.  Retained products of conception have been ruled out by ultrasound.
    4.  There is guaranteed outpatient follow-up with obstetrics within 24 to 48 hours.
    5.  The patient is provided with strict return precautions (e.g., saturating **more than 2 sanitary pads per hour**, fever, or worsening pelvic pain).

6. THE DANGER ZONE (Pitfalls & Critical Actions)

Deadly Cognitive Traps & Trainee Errors:

• The "Normal Blood Pressure" Reassurance: Falsely assuming a postpartum bleeding patient is stable because her blood pressure is normal. Healthy young obstetric patients will compensate hemodynamically until they have lost \(\ge\) 1,500 mL of blood, after which they will rapidly collapse into profound hemorrhagic shock.
• The Vaginal Packing Trap: Attempting to pack the vaginal vault with gauze in a patient with active postpartum hemorrhage. Vaginal packing is strictly contraindicated in the ED, as it does not compress the bleeding endometrial cavity, fails to stimulate myometrial tone, increases infection risk, and dangerously conceals ongoing, rapid intrauterine blood loss.
• Refractory Shock Vasopressor Rush: Administering vasopressors (such as norepinephrine) as a first-line therapy for hypotension in postpartum hemorrhage before volume and blood products have been replaced. Vasopressors cause severe uteroplacental and systemic vasoconstriction, worsening end-organ ischemia.
• Failing to Inspect for Trauma in a Firm Uterus: Attributing all postpartum bleeding to uterine atony. If a patient is bleeding heavily but the uterine fundus is firm, contracted, and non-boggy, the cause is almost certainly a genital tract laceration or hematoma, which requires immediate surgical laceration repair or hematoma drainage, not more uterotonics.
• Underestimating the Retained Placenta Timeline: Failing to identify a delayed third stage of labor. If the placenta is not delivered within 18 to 30 minutes after the infant, there is a 6-fold increase in the risk of postpartum hemorrhage, requiring manual or surgical exploration.

Board-Mandated Critical Actions:

• Initiate immediate bimanual uterine massage and start high-dose IV oxytocin (20 to 40 IU) as the absolute first step in any postpartum patient presenting with heavy vaginal bleeding and a boggy uterus.
• Never perform vaginal packing to control postpartum hemorrhage in the ED.
• Avoid the administration of Methylergonovine (Methergine) in any patient with chronic hypertension, preeclampsia, or gestational hypertension.
• Avoid the administration of Carboprost (Hemabate) in any patient with a history of active asthma.

7. MCQ MASTERCLASS (Written Exam Tips)

• High-Yield "Buzzwords":
• "Postpartum patient G1P1 presents with persistent, brisk, bright red vaginal bleeding; on examination, her uterine fundus is noted to be firm, hard, and well-contracted" \(\rightarrow\) Genital Tract Laceration (Trauma) (differentiate from atony, where the uterus is boggy and soft).
• "Postpartum hemorrhage patient receives multiple uterotonics; subsequently develops severe, refractory bronchospasm" \(\rightarrow\) Carboprost (Hemabate) side effect (due to prostaglandin-induced airway smooth muscle constriction; strictly contraindicated in asthmatics).
• "Postpartum patient G3P2 who delivered at home presents with shock and heavy bleeding; her blood pressure is 82/44 and heart rate is 58 bpm" \(\rightarrow\) Cervical Shock / Uterine Inversion (vagal stimulation from tissue trapped in the cervix or a prolapsed uterus causes a classic paradoxical bradycardia in the setting of severe hypotension).
• "Postpartum hemorrhage shock followed months later by failure to lactate, amenorrhea, and profound fatigue" \(\rightarrow\) Sheehan Syndrome (postpartum pituitary necrosis secondary to severe hemorrhagic shock).
• Distractor Buster:
• The "Next Step in a Firm Uterus" Trap: An exam question will present a postpartum patient bleeding heavily with a firm, well-contracted uterus, and the distractors will include "administer Methergine," "administer Hemabate," or "perform bimanual massage." Do not choose these! Because the uterus is firm, there is no atony. The correct answer is "Perform a thorough speculum examination under a direct light source to evaluate for vaginal or cervical lacerations".
• The "First-Line Drug" Distractor: A patient has postpartum bleeding due to atony, and the options list "Oxytocin 10-40 IU IV," "Methergine 0.2 mg IM," "Hemabate 250 μg IM," and "Misoprostol 800 μg SL." All are uterotonics, but Oxytocin is the gold-standard, first-line agent; the others are reserved for refractory cases.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

Mandatory OSCE Communication Actions:

• Simultaneous Multi-Specialist Mobilization: "I am immediately activating our institution's Obstetric Hemorrhage Protocol, mobilizing a multidisciplinary team including Obstetrics, Anesthesiology, the Blood Bank, and Neonatology to the resuscitation bay".
• Tone and Bleeding Source Declaration: "For the record, I am stating that I am performing a thorough, chaperoned abdominal, perineal, and speculum examination under a direct light source. I am assessing uterine fundal tone to differentiate uterine atony from genital tract lacerations, expanding pelvic hematomas, or retained products of conception".

High-Yield Phrasing to Use under High-Stress Testing:

• Resuscitation Command: "Resuscitation of the mother takes absolute priority and is the single most effective way to maintain organ perfusion. I am placing two large-bore 14-gauge IV lines above the diaphragm, ordering a Type and Crossmatch for 6 units of packed red blood cells, and initiating rapid volume expansion with warm isotonic crystalloids. If she remains hemodynamically unstable after 2 units of PRBCs, I will activate our Massive Transfusion Protocol in a balanced 1:1:1 ratio of PRBCs, fresh frozen plasma, and platelets".
• Uterine Massage and Oxytocin Command: "Because uterine atony is the most common cause of postpartum hemorrhage, I am immediately performing aggressive, continuous bimanual uterine massage, placing one hand in the anterior vaginal fornix and compressing the uterine fundus against my other hand on the abdominal wall. Simultaneously, I am administering Oxytocin 20 International Units in 1,000 mL of normal saline as a continuous IV infusion to stimulate myometrial contraction".
• Methergine Safety Command: "My bimanual massage and oxytocin have failed to arrest the bleeding. I will now administer Methergine 0.2 mg IM. However, I am checking the patient's records first to confirm she has no history of chronic hypertension, preeclampsia, or gestational hypertension, as Methergine is strictly contraindicated in these patients due to the risk of precipitating a stroke".
• Hemabate Safety Command: "The bleeding remains refractory. I will administer Carboprost (Hemabate) 250 micrograms IM. I am explicitly verifying that the patient has no history of active asthma, as Carboprost is strictly contraindicated in asthmatics due to the risk of severe bronchospasm".
• Intrauterine Tamponade Directive: "Despite maximum medical therapy, severe hemorrhage from uterine atony persists. I am now preparing to place an intrauterine balloon tamponade device, such as a Bakri balloon, instilling 30 mL of sterile saline, to mechanically compress the bleeding endometrial sinuses while we prepare the patient for emergent transfer to the operating room for definitive surgical intervention or to interventional radiology for uterine artery embolization".